Addus HomeCare (NASDAQ:ADUS) Given New $145.00 Price Target at TD Cowen

Addus HomeCare (NASDAQ:ADUS – Get Free Report) had its price objective boosted by research analysts at TD Cowen from $131.00 to $145.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen‘s price objective points to a potential upside of 15.30% from the stock’s current price.

A number of other research firms also recently weighed in on ADUS. Weiss Ratings upgraded Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. Truist Financial upped their price target on shares of Addus HomeCare from $135.00 to $148.00 and gave the company a “buy” rating in a research report on Thursday. Bank of America cut Addus HomeCare from a “buy” rating to a “neutral” rating and cut their target price for the stock from $140.00 to $125.00 in a research report on Monday, September 14th. Barclays raised their target price on shares of Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a report on Wednesday. Finally, Citigroup lowered shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a report on Monday, September 14th. Six analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of “Hold” and a consensus price target of $131.89.

Get Our Latest Stock Analysis on Addus HomeCare

Addus HomeCare Price Performance

Shares of ADUS stock traded down $2.18 during trading on Thursday, hitting $125.76. The company had a trading volume of 163,972 shares, compared to its average volume of 236,738. The stock has a market capitalization of $2.35 billion, a price-to-earnings ratio of 21.01, a price-to-earnings-growth ratio of 1.80 and a beta of 0.75. Addus HomeCare has a 52 week low of $87.95 and a 52 week high of $131.59. The stock’s 50-day moving average is $117.35 and its two-hundred day moving average is $106.71. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. The firm had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.37%. The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.56 EPS. As a group, analysts predict that Addus HomeCare will post 6.33 EPS for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently made changes to their positions in ADUS. NFJ Investment Group LLC purchased a new stake in Addus HomeCare during the 2nd quarter valued at about $29,000. Heritage Family Offices LLP acquired a new stake in Addus HomeCare during the 3rd quarter valued at approximately $43,000. Parallel Advisors LLC boosted its holdings in shares of Addus HomeCare by 66.3% in the 1st quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock valued at $38,000 after acquiring an additional 161 shares during the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Addus HomeCare by 16.9% in the third quarter. Nisa Investment Advisors LLC now owns 769 shares of the company’s stock worth $85,000 after acquiring an additional 111 shares during the period. Finally, State of Wyoming acquired a new stake in shares of Addus HomeCare in the second quarter worth $79,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

  • Positive Sentiment: Q3 earnings beat on profit. Addus reported adjusted EPS of $1.83, above the roughly $1.79 consensus and up from $1.56 a year earlier. Revenue rose 7% to $387.7 million, though it was slightly below analyst estimates. The profit growth is a positive signal, with the small revenue miss a qualification. Addus Q3 2026 earnings call highlights
  • Positive Sentiment: AccentCare deal and margin outlook offer a growth catalyst. Addus outlined a Q1 2027 expected closing for its acquisition of AccentCare’s personal care division and expects full-year adjusted EBITDA margin in the 13% range. The acquisition could expand its personal-care platform, although execution and closing remain ahead. Addus outlines AccentCare close and margin outlook
  • Neutral Sentiment: Medicaid policy is a possible but uncertain tailwind. Post-election discussion of Medicare for All has put home-care providers such as Addus in focus, given its Medicaid exposure and the proposals’ emphasis on home- and community-based care. Legislation is not imminent, and any benefit would depend on final reimbursement rules. Could the Midterms Revive Medicare for All?
  • Neutral Sentiment: Caregiver scheduling remains an operational balancing act. Caregivers’ preference for 40-hour workweeks is shaping Addus’ personal-care census strategy. Better alignment could help staffing, but the effect on service capacity and growth is not yet clear. Caregiver desires for 40-hour weeks shape Addus strategy
  • Negative Sentiment: Barclays maintained an underweight view. The firm raised its price target from $96 to $101 but still rated the shares “underweight,” signaling concern that the stock’s valuation leaves downside risk. Barclays stock recommendations

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.

Further Reading

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.